TLGT - Teligent, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
3.47
+0.05 (+1.46%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close3.42
Open3.42
Bid3.00 x 700
Ask0.00 x 0
Day's range3.38 - 3.57
52-week range2.43 - 9.54
Volume396,850
Avg. volume694,796
Market cap185.634M
Beta0.60
PE ratio (TTM)N/A
EPS (TTM)-0.28
Earnings date28 Jul 2017 - 31 Jul 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.11
Trade prices are not sourced from all markets
  • Associated Presslast month

    Teligent reports 4Q loss

    The Buena, New Jersey-based company said it had a loss of 11 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 6 cents per share. The specialty generic pharmaceutical ...

  • Generic Drugmakers to Dump as Teva's Woes Continue in 2018
    Zacks2 months ago

    Generic Drugmakers to Dump as Teva's Woes Continue in 2018

    The generic industry is facing several challenges pulling down several companies including Teva (TEVA).

  • Globe Newswire3 months ago

    Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer

    Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that Damian Finio has been appointed Chief Financial Officer of Teligent, Inc., effective February 5, 2018. Mr. Finio is currently the CFO of Virtus Pharmaceuticals, Inc., and will succeed Jenniffer Collins, who is leaving Teligent to pursue personal and professional opportunities and has agreed to stay on through May in a transitional capacity.

  • Here's Why Teligent Stock Was Cut Nearly in Half Today
    Motley Fool6 months ago

    Here's Why Teligent Stock Was Cut Nearly in Half Today

    Third-quarter 2017 results show the company's high-growth business model is not without risks.

  • Associated Press6 months ago

    Teligent reports 3Q loss

    On a per-share basis, the Buena, New Jersey-based company said it had a loss of 12 cents. Losses, adjusted for non-recurring costs and amortization costs, came to 8 cents per share. The results did not ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes